MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment

被引：0
|
作者：
Xiaoyue Xu
Shaorong Yu
Wenbo Sun
Xiaobing Qin
Yan Chen
Leilei Zhou
Rui Lou
Shuchen Dong
Bo Shen
Jianzhong Wu
Jialan Zang
Haixia Cao
Meiqi Shi
Qin Zhang
Jifeng Feng
机构：
[1] Jiangsu Institute of Cancer Research,Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital
[2] Nanjing Medical University Affiliated Brain Hospital,Department of Neurosurgery
[3] Xuzhou First People’s Hospital,Department of Oncology, Huai’an First People’s Hospital
[4] Nanjing Medical University,Department of Oncology
[5] The First Hospital of Harbin City,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
Lung adenocarcinoma; MiRNA; Platinum resistance; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 438
页数：7
相关论文
共 50 条
  • [21] NANOG Predicts Poor Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Lee, Seung Hyeun
    Park, Myung Jae
    Park, So Young
    In, Kwang Ho
    Kim, Chul Hwan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S959 - S960
  • [22] Bevacizumab in routine clinical practice for first-line therapy with platinum-based chemotherapy of patients with advanced adenocarcinoma of the lung in Germany
    Wirtz, H. R.
    Lang, S.
    Mezger, J.
    Hammerschmidt, S.
    Gaska, T.
    Lerchenmueller, C.
    Reck, M.
    Haas, S.
    Reichert, D.
    Hoeffken, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Markers of response to platinum-based chemotherapy in lung cancer
    Barr, Martin P.
    MacDonagh, Lauren
    O'Byrne, Kenneth J.
    LUNG CANCER MANAGEMENT, 2013, 2 (03) : 227 - 239
  • [24] Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet
    Kozlowska, Emilia
    Suwinski, Rafal
    Giglok, Monika
    Swierniak, Andrzej
    Kimmel, Marek
    PLOS COMPUTATIONAL BIOLOGY, 2020, 16 (10)
  • [25] A Tumor-Genetic Signature of Patients' Prognosis and Response to a Platinum-Based Treatment in High-Grade Ovarian Cancer
    Roncato, R.
    Toffoli, G.
    Montico, M.
    Gagno, S.
    Garziera, M.
    Poletto, E.
    De Mattia, E.
    Sorio, R.
    Canzonieri, V.
    Giorda, G.
    Cecchin, E.
    PUBLIC HEALTH GENOMICS, 2016, 19 : 7 - 7
  • [26] Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer
    Wang, Xin
    Zhao, Jun
    Yang, Lu
    Mao, Li
    An, Tongtong
    Bai, Hua
    Wang, Shuhang
    Liu, Xuyi
    Feng, Guoshuang
    Wang, Jie
    MEDICAL ONCOLOGY, 2010, 27 (02) : 484 - 490
  • [27] Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer
    Xin Wang
    Jun Zhao
    Lu Yang
    Li Mao
    Tongtong An
    Hua Bai
    Shuhang Wang
    Xuyi Liu
    Guoshuang Feng
    Jie Wang
    Medical Oncology, 2010, 27 : 484 - 490
  • [28] Development of a miRNA-seq based prognostic signature in lung adenocarcinoma
    Chathura Siriwardhana
    Vedbar S. Khadka
    John J. Chen
    Youping Deng
    BMC Cancer, 19
  • [29] Development of a miRNA-seq based prognostic signature in lung adenocarcinoma
    Siriwardhana, Chathura
    Khadka, Vedbar S.
    Chen, John J.
    Deng, Youping
    BMC CANCER, 2019, 19 (1)
  • [30] PROGNOSTIC IMPORTANCE OF RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Radosavljevic, D.
    Kezic, I.
    Jelic, S.
    Golubicic, I.
    ANNALS OF ONCOLOGY, 2008, 19 : 111 - 111
12345